omniture

China Cord Blood Corporation to Announce Third Quarter Fiscal 2010 Earnings Results

2010-03-01 21:20 1719

Earnings Call Scheduled for March 5, 2010

HONG KONG, March 1 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO; "the Company") today announced its plan to release financial results for the third quarter of fiscal year 2010 on Friday, March 5, 2010, before the market opens in the US.

The Company will hold a teleconference at 8:00 a.m. EST on Friday, March 5, 2010 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the following link: http://phx.corporate-ir.net/playerlink.zhtml?c=206671&s=wm&e=2770193 . A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or 852-2475-0994 for Hong Kong callers, access code: 59252599.

Supplemental financial information referenced in the conference call and the text of the third quarter press release can be found at http://www.chinacordbloodcorp.com , in the section titled Investor Center/Press Release, after 7:30 a.m. EST on the morning of the conference call.

Please dial in ten minutes prior to the conference to ensure proper connection. Please be prepared to provide your name and company to the operator.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing, Guangdong and Shandong). Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses has been issued as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com .

For more information, please contact:

China Cord Blood Corporation

Ms. Joe-ling Law

Tel: +852-3605-8180

Email: joeling.law@chinacordbloodcorp.com

Integrated Corporate Relations, Inc.

In New York:

Ashley M. Ammon or Christine Duan

Tel: +1-646-277-1227

In Beijing:

Wei-Jung Yang

Tel: +86-10-6599-7968

Source: China Cord Blood Corporation
Related Stocks:
NYSE:CO
collection